Healthcare & Life Sciences
Spur Therapeutics
series-b
series-b
Stage
2
Investors
About
Spur Therapeutics is a clinical-stage biotechnology company developing gene therapies for debilitating chronic conditions focused on advancing long-term disease management through gene therapy modalities.
Explore Spur Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.